Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/10/2013WO2013151161A1 Novel compound, method for producing same and antitumor agent
10/10/2013WO2013151082A1 Aqueous liquid beverage
10/10/2013WO2013151042A1 Melanin production inhibitor
10/10/2013WO2013151033A1 C-glycoside derivative having a spiro ring
10/10/2013WO2013150993A1 Pharmaceutical for preventing or treating gingivitis
10/10/2013WO2013150771A1 Composition and method for the safe and effective inhibition of pancreatic lipase in mammals
10/10/2013WO2013150544A2 Ivabradine hydrochloride solid dispersion
10/10/2013WO2013150534A1 Novel targeting agents for diagnostic and therapeutic indications
10/10/2013WO2013150529A2 Indole, indoline derivatives, compositions comprising them and uses thereof
10/10/2013WO2013150471A1 Steroid sulfatase inhibitor regimen for the treatment of endometriosis
10/10/2013WO2013150469A1 Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis
10/10/2013WO2013150416A1 Diacylglycerol acyltransferase 2 inhibitors
10/10/2013WO2013150384A1 Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
10/10/2013WO2013150354A1 Local composition to treat stress urinary incontinence in a female subject
10/10/2013WO2013150322A1 Prasugrel-containing immediate release stable oral pharmaceutical compositions
10/10/2013WO2013150303A1 Stem cell microparticles
10/10/2013WO2013150296A1 Heterobicyclic compounds as beta-lactamase inhibitors
10/10/2013WO2013150295A1 Food supplement to support brain function
10/10/2013WO2013150292A1 Composition for the treatment of inflammatory and immune disorders
10/10/2013WO2013150277A1 Ophthalmic therapy
10/10/2013WO2013150173A1 New alpha2 adrenoceptor agonists
10/10/2013WO2013150153A1 Ketone bodies and ketone body esters for maintaining or improving muscle power output
10/10/2013WO2013150150A1 An h3 receptor antagonist for use in the treatment of alzheimer's disease
10/10/2013WO2013150140A1 New pyrido [3.4-c] [1.9] phenanthroline and 11, 12 dihydropyrido [3.4 -c] [1.9] phenanthroline derivatives and the use thereof, particularly for treating cancer
10/10/2013WO2013150117A1 Radiotracer, in particular for alzheimer's disease
10/10/2013WO2013150115A1 N- substituted hetero - bicyclic compounds and derivatives for combating animal pests
10/10/2013WO2013150087A1 Fe(iii)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia
10/10/2013WO2013150036A1 Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof
10/10/2013WO2013150032A1 A dopamine-agonist-containing transdermal application system
10/10/2013WO2013149997A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors
10/10/2013WO2013149987A1 Pharmaceutical formulations comprising ccr3 antagonists
10/10/2013WO2013149986A1 Use of ccr3-inhibitors
10/10/2013WO2013149977A1 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators
10/10/2013WO2013149976A1 Indole-pyrimidine derivatives and their therapeutic uses
10/10/2013WO2013149959A1 Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one
10/10/2013WO2013149948A1 New alkylating agents
10/10/2013WO2013149946A1 Functionalized thieno-indole derivatives for the treatment of cancer
10/10/2013WO2013149909A1 Amino-substituted imidazopyridazines
10/10/2013WO2013149903A1 N- substituted hetero - bicyclic furanone derivatives for combating animal
10/10/2013WO2013149800A1 Carboxamide compounds and their use as calpain inhibitors v
10/10/2013WO2013149704A1 Cyclic amides as metap-2 inhibitors
10/10/2013WO2013149581A1 Combination products with tyrosine kinase inhibitors and their use
10/10/2013WO2013149580A1 Timosaponin compounds
10/10/2013WO2013149538A1 Pharmaceutical composition
10/10/2013WO2013149470A1 Bisbenzylisoquinoline compound or pharmaceutically acceptable salt treatment and new application in easing depression symptom
10/10/2013WO2013149384A1 Brain atrophy prevention agent
10/10/2013WO2013149376A1 Chemokine receptor antagonists
10/10/2013WO2013149362A1 1-(dihydronaphthalenyl)pyridones as melanin-concentrating hormone receptor 1 antagonists
10/10/2013WO2013149336A1 5-nitrofuran-2-carboxamide derivatives for inhibiting centrosomal clustering
10/10/2013WO2013149322A1 Preventing or treating periodontal disease
10/10/2013WO2013122375A3 Pharmaceutical composition for viral treatment, and method for screening antiviral agent
10/10/2013WO2013115619A3 Novel antibacterial compound
10/10/2013WO2013108270A4 Curcumin coated magnetite nanoparticles for biomedical applications
10/10/2013WO2013106761A3 Antimicrobial agents
10/10/2013WO2013106756A3 Antimicrobial agents
10/10/2013WO2013104598A3 Substituted, annulated imidazoles and pyrazoles, and use thereof
10/10/2013WO2013100881A3 Combined pharmaceutical formulation containing diacerein
10/10/2013WO2013095319A3 Formulations of flurbiprofen and diacerein
10/10/2013WO2013095317A3 Pharmaceutical formulations of flurbiprofen and glucosamin
10/10/2013WO2013091062A3 Aldimine-derived compounds, pharmaceutical compositions and use
10/10/2013WO2013090842A3 Ophthalmic compositions comprising polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol graft copolymers (soluplus)
10/10/2013WO2013090454A3 Carboxylic acid derivatives comprising four cycles acting as glp-1 receptor modulators for therapy of diseases such as diabetes
10/10/2013WO2013086649A3 Flavonols as agonists of coenzyme q(ubiquinone and ubiquinol) in the modulation of the activity of mitochondrial electron transport chain complexes
10/10/2013WO2013080225A3 Novel parenteral controlled release formulations of nsaid's
10/10/2013WO2013077814A3 Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy
10/10/2013WO2013068850A8 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES
10/10/2013WO2013056148A3 Scd1 antagonists for treating cancer
10/10/2013WO2013054337A9 Extended release pharmaceutical compositions of fesoterodine
10/10/2013WO2013054178A9 Extended release pharmaceutical compositions containing carbamazepine
10/10/2013WO2012160713A8 Learning and memory improver
10/10/2013WO2012139485A8 Oral solid preparation of compound antituberculosis drug and preparation method thereof
10/10/2013WO2012091523A8 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
10/10/2013WO2012083185A3 Peptide-based in vivo sirna delivery system
10/10/2013WO2012040295A3 Therapeutic applications of smad7
10/10/2013WO2012030944A3 Quinoline and isoquinoline derivatives for use as jak modulators
10/10/2013WO2012027481A9 Compounds for treatment of cancer
10/10/2013WO2012021647A3 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
10/10/2013WO2012013967A3 New uses
10/10/2013US20130267916 Percutaneous absorption preparation containing rivastigmine
10/10/2013US20130267713 Hepatitis C Virus Inhibitors
10/10/2013US20130267606 Use of vitamin k for weight maintenance and weight control
10/10/2013US20130267605 Aqueous composition comprising bromhexine
10/10/2013US20130267601 Method for prevention of alzheimer's disease
10/10/2013US20130267598 Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of reducing sebum production using same
10/10/2013US20130267596 Methods of Reducing Hair Loss and/or Facilitating Hair Growth and/or Regrowth
10/10/2013US20130267595 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/10/2013US20130267593 Methods and compositions for administration of oxybutynin
10/10/2013US20130267591 Novel ophthalmic compositions
10/10/2013US20130267590 Retigabine compositions
10/10/2013US20130267585 Pharmaceutical composition having a cationic excipient
10/10/2013US20130267580 Compositions and Methods for the Diagnosis and Therapy of BCL2-Associated Cancers
10/10/2013US20130267577 Gene Silencing by Single-Stranded Polynucleotides
10/10/2013US20130267573 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
10/10/2013US20130267568 (1,2,3-Triazolyl)sulfonyl Derivatives
10/10/2013US20130267567 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamic acid ethyl ester and an arylpropionic acid
10/10/2013US20130267566 Durable treatment with 4-aminopyridine in patients with demyelination
10/10/2013US20130267560 Sustained release pharmaceutical compositions of donepezil
10/10/2013US20130267558 Pharmaceutical composition for treating or preventing alcoholic liver diseases, containing cilostazol as active ingredient
10/10/2013US20130267557 Combined Use of an Alpha-Adrenergic Receptor Antagonist and an Anti-Muscarinic Agent
1 ... 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 ... 7860